Dana A. Chitu
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy.
Journal: American journal of hematology
Published: January 29, 2026
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia.
Journal: Blood neoplasia
Published: December 02, 2025
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents.
Journal: Leukemia
Published: November 09, 2024
Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients.
Journal: Haematologica
Published: August 05, 2024
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome.
Journal: Annals of hematology
Published: July 23, 2024
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Journal: The Lancet. Haematology
Published: August 02, 2023
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.
Journal: Leukemia
Published: June 30, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Journal: Blood cancer journal
Published: March 26, 2023
Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome.
Journal: BMC infectious diseases
Published: August 15, 2022
Feasibility, SAR Distribution, and Clinical Outcome upon Reirradiation and Deep Hyperthermia Using the Hypercollar3D in Head and Neck Cancer Patients.
Journal: Cancers
Published: September 16, 2021
Dysplasia and PNH-type cells in bone marrow aspirates of myelodysplastic syndromes.
Journal: Cytometry. Part B, Clinical cytometry
Published: July 01, 2021
Last Updated: 09/26/2026